Alphinity Investment Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Yum China
YUMC
|
+$24.6M |
| 2 |
Lowe's Companies
LOW
|
+$24.1M |
| 3 |
UnitedHealth
UNH
|
+$17.4M |
| 4 |
Microsoft
MSFT
|
+$16.2M |
| 5 |
Lumentum
LITE
|
+$14.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Wells Fargo
WFC
|
+$13.5M |
| 2 |
Nomad Foods
NOMD
|
+$10.3M |
| 3 |
Merck
MRK
|
+$7.62M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$2.71M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 18.18% |
| 2 | Technology | 17.52% |
| 3 | Communication Services | 14.98% |
| 4 | Healthcare | 14.7% |
| 5 | Consumer Staples | 10.11% |
Similar funds
Alphinity Investment Management's Q1 2019 Portfolio in Review
As of Q1 2019, Alphinity Investment Management held 26 positions worth $703M, up 57% from $448M the previous quarter. Its ten largest holdings account for 53% of the portfolio.
Alphinity Investment Management deployed $180M of net new capital in Q1 2019, opening 3 new positions and adding to 19 existing holdings. Its largest new stake was Yum China: 623,807 shares worth $28M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 18% of assets, up from 11% a quarter earlier, followed by Technology and Communication Services.
On the sell side, the largest reduction was Merck, an estimated $7.62M trimmed.
- Alphinity Investment Management's largest Q1 2019 buy was Yum China: 623,807 shares worth $28M.
- Alphinity Investment Management added most to UnitedHealth in Q1 2019, an estimated $17.4M increase.
- Alphinity Investment Management's biggest Q1 2019 reduction was Merck, cutting an estimated $7.62M.
- Alphinity Investment Management fully exited Wells Fargo in Q1 2019, selling an estimated $13.5M.
- Alphinity Investment Management's ten largest holdings make up 53% of its $703M portfolio in Q1 2019.
- Alphinity Investment Management opened 3 new positions and closed 2 in Q1 2019.
- Alphinity Investment Management's portfolio value rose 57% quarter-over-quarter to $703M.
Based on Alphinity Investment Management's 13F filing for Q1 2019, filed 14 May 2019.